Clinical Trial Update: Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 dose-escalation trial of Abiraterone Acetate in prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED